Amal A.M. Eissa

424 total citations
11 papers, 372 citations indexed

About

Amal A.M. Eissa is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Amal A.M. Eissa has authored 11 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Amal A.M. Eissa's work include Synthesis and biological activity (8 papers), Click Chemistry and Applications (3 papers) and Quinazolinone synthesis and applications (3 papers). Amal A.M. Eissa is often cited by papers focused on Synthesis and biological activity (8 papers), Click Chemistry and Applications (3 papers) and Quinazolinone synthesis and applications (3 papers). Amal A.M. Eissa collaborates with scholars based in Egypt and Yemen. Amal A.M. Eissa's co-authors include Sahar M. Abou‐Seri, Kamilia M. Amin, Ghaneya S. Hassan, Fadi M. Awadallah, Nahla A. Farag, Gamal A. Soliman, Mohamed M. Abdulla, Farghaly A. Omar, Heba Abdelrasheed Allam and Hany S. Ibrahim and has published in prestigious journals such as RSC Advances, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Amal A.M. Eissa

11 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amal A.M. Eissa Egypt 10 309 110 80 40 33 11 372
Afaf El‐Malah Egypt 14 308 1.0× 145 1.3× 105 1.3× 41 1.0× 34 1.0× 27 434
Neil S. Cutshall United States 8 263 0.9× 110 1.0× 54 0.7× 43 1.1× 21 0.6× 8 372
Manal M. Kandeel Egypt 10 349 1.1× 94 0.9× 43 0.5× 27 0.7× 38 1.2× 30 395
Yasmine M. Abdel Aziz Egypt 12 296 1.0× 127 1.2× 47 0.6× 62 1.6× 53 1.6× 19 394
K. Hajela India 13 279 0.9× 111 1.0× 73 0.9× 35 0.9× 36 1.1× 21 412
Madlen B. Labib Egypt 13 445 1.4× 100 0.9× 174 2.2× 49 1.2× 43 1.3× 17 530
Yasmin M. Syam Egypt 13 383 1.2× 184 1.7× 84 1.1× 80 2.0× 25 0.8× 25 527
Fabien Julémont Belgium 11 193 0.6× 77 0.7× 186 2.3× 40 1.0× 23 0.7× 14 370
Amel M. Farrag Egypt 11 335 1.1× 143 1.3× 47 0.6× 41 1.0× 46 1.4× 23 414
Sven George Germany 11 113 0.4× 103 0.9× 93 1.2× 35 0.9× 13 0.4× 19 316

Countries citing papers authored by Amal A.M. Eissa

Since Specialization
Citations

This map shows the geographic impact of Amal A.M. Eissa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal A.M. Eissa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal A.M. Eissa more than expected).

Fields of papers citing papers by Amal A.M. Eissa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amal A.M. Eissa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal A.M. Eissa. The network helps show where Amal A.M. Eissa may publish in the future.

Co-authorship network of co-authors of Amal A.M. Eissa

This figure shows the co-authorship network connecting the top 25 collaborators of Amal A.M. Eissa. A scholar is included among the top collaborators of Amal A.M. Eissa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal A.M. Eissa. Amal A.M. Eissa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Eissa, Amal A.M., et al.. (2021). Design and synthesis of novel furan, furo[2,3-d]pyrimidine and furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as potential VEGFR-2 inhibitors. Bioorganic Chemistry. 116. 105336–105336. 20 indexed citations
2.
Eissa, Amal A.M., et al.. (2021). Design and synthesis of novel pyridopyrimidine derivatives with anchoring non-coplanar aromatic extensions of EGFR inhibitory activity. Bioorganic Chemistry. 116. 105318–105318. 24 indexed citations
3.
4.
Ragab, Fatma A., et al.. (2021). Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents. Archiv der Pharmazie. 354(8). e2100029–e2100029. 13 indexed citations
5.
Ragab, Fatma A., et al.. (2021). Novel coumarin–pyrazoline hybrids: synthesis, cytotoxicity evaluation and molecular dynamics study. New Journal of Chemistry. 45(40). 19043–19055. 14 indexed citations
6.
7.
Eissa, Amal A.M., et al.. (2015). CHARACTERIZATION OF CARBAPENEMASE PRODUCER ENTEROBACTERIACEAE ISOLATED IN THE UNITED ARAB EMIRATES. 1 indexed citations
8.
Amin, Kamilia M., Sahar M. Abou‐Seri, Fadi M. Awadallah, et al.. (2014). Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells. European Journal of Medicinal Chemistry. 90. 221–231. 53 indexed citations
9.
Amin, Kamilia M., Amal A.M. Eissa, Sahar M. Abou‐Seri, Fadi M. Awadallah, & Ghaneya S. Hassan. (2012). Synthesis and biological evaluation of novel coumarin–pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents. European Journal of Medicinal Chemistry. 60. 187–198. 116 indexed citations
10.
Amin, Kamilia M., et al.. (2011). Design, synthesis and vasorelaxant evaluation of novel coumarin–pyrimidine hybrids. Bioorganic & Medicinal Chemistry. 19(20). 6087–6097. 53 indexed citations
11.
Eissa, Amal A.M., Nahla A. Farag, & Gamal A. Soliman. (2009). Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents. Bioorganic & Medicinal Chemistry. 17(14). 5059–5070. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Afaf El‐Malah Breakdown of academic impact, for papers by Neil S. Cutshall Breakdown of academic impact, for papers by Manal M. Kandeel Breakdown of academic impact, for papers by Yasmine M. Abdel Aziz Breakdown of academic impact, for papers by K. Hajela Breakdown of academic impact, for papers by Madlen B. Labib Breakdown of academic impact, for papers by Yasmin M. Syam Breakdown of academic impact, for papers by Fabien Julémont Breakdown of academic impact, for papers by Amel M. Farrag Breakdown of academic impact, for papers by Sven George
Rankless by CCL
2026